NCT01058915View on ClinicalTrials.gov

Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Rosuvastatin 5mg

Rosuvastatin 5mg/day

DRUG

Rosuvastatin 40mg

Rosuvastatin 40mg/day

Trial Locations (1)

5000

Department of Cardiology, Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT01058915 - Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI) | Biotech Hunter | Biotech Hunter